P95 BV (“P95”), a leading global provider of epidemiology and clinical …
Innovations CfP_Focus Area 2: Vaccine candidates for priority pathogens and viral families
Information CFP ID: CFP-144 Submission Deadline: 12/14/2026 Background CEPI’s Innovations to Prepare …
Innovations CfP_Focus Area 1: Innovative vaccine platforms that can transform outbreak response
Information CFP ID: CFP-143 Submission Deadline: 12/14/2026 Background CEPI’s Innovations to Prepare …
Intradermal vaccination, a promising solution for Mpox immunization
Mpox has been a persistent public health issue, particularly in the Democratic …
Possible vaccine against lung cancer in 2030: ‘Big step forward’
BioNTech is the second major vaccine manufacturer to start tests for a …
Global Health EDCTP3 launches research projects to combat MPOX
On the 14th of August 2024, the World Health Organization (WHO) declared …
New vaccine platforms
A conversation with the father of reverse vaccinology, Prof. Rino Rappuoli Authors: …
10th edition of the Master in Vaccinology and Drug Development.
The Institute for Global Health, University of Siena is proud to announce …
Socio-Economic Value of Adult Immunisation Programmes
Adult vaccines can return up to 19 times their initial investment to …
Whooping cough and measles are on the rise in Flanders: ‘This is partly due to vaccination fatigue’
In Flanders, 1,885 cases of whooping cough have been registered this year …